SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-050797
Filing Date
2023-02-27
Accepted
2023-02-27 16:22:11
Documents
16
Period of Report
2023-02-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d452663d8k.htm   iXBRL 8-K 31842
2 EX-10.1 d452663dex101.htm EX-10.1 10449
3 EX-10.2 d452663dex102.htm EX-10.2 60956
4 EX-99.1 d452663dex991.htm EX-99.1 14721
8 GRAPHIC g452663g0227185324928.jpg GRAPHIC 3812
  Complete submission text file 0001193125-23-050797.txt   275044

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20230224.xsd EX-101.SCH 2851
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20230224_lab.xml EX-101.LAB 17236
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20230224_pre.xml EX-101.PRE 10813
10 EXTRACTED XBRL INSTANCE DOCUMENT d452663d8k_htm.xml XML 3267
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 23675244
SIC: 2834 Pharmaceutical Preparations